As illustrated by the recent discovery of the role of ROCK2 in autoimmunity and the therapeutic effects of its selective inhibitor 100, unraveling the roles of Rho and Rho effectors further in various pathophysiological settings by the above approach may reveal unappreciated therapeutic possibilities. The gene discussed is ROCK2; the disease is Autoimmunity.